_ok_o_ff.png)
1.png)
Cross Sectional Analysis of Risk Factors for Advanced CKD in Hemodialysis at RSUD Dr. Hasri Ainun Habibie
Abstract
Chronic Kidney Disease (CKD) is a major non-communicable disease associated with high morbidity, mortality, and healthcare costs worldwide. This study aimed to analyze factors associated with CKD stage among patients undergoing hemodialysis at RSUD Dr. Hasri Ainun Habibie, Gorontalo Province, Indonesia. A quantitative observational study with a cross-sectional design was conducted among 53 hemodialysis patients using a total sampling technique. Data were analyzed using univariate analysis, bivariate analysis with the Chi-square test, and multivariate analysis using multiple logistic regression. The results showed that the majority of patients were in the advanced stage of CKD (62.3%) and belonged to the young elderly age group (60–69 years). Bivariate analysis demonstrated that age (p < 0.001), family history of CKD (p < 0.001), history of urinary tract infection (p = 0.002), heart disease (p = 0.013), diabetes mellitus (p = 0.001), hypertension (p < 0.001), smoking habits (p = 0.032), and energy drink consumption (p = 0.046) were significantly associated with CKD stage. Multivariate logistic regression analysis identified age (p = 0.008), family history of CKD (p = 0.039), history of heart disease (p = 0.031), and hypertension (p = 0.018) as independent factors associated with advanced-stage CKD, with hypertension showing the strongest association. In conclusion, advanced-stage CKD among hemodialysis patients is associated with increasing age and chronic comorbid conditions, particularly hypertension and cardiovascular disease. Strengthening early screening programs and optimizing the management of hypertension and cardiovascular risk factors are essential to prevent CKD progression and reduce the burden of hemodialysis.
Keywords
Full Text:
PDFReferences
Global Burden of Disease (GBD) Collaborative Network, Global Burden of Disease Study 2020 Results. Seattle, WA, USA: Institute for Health Metrics and Evaluation (IHME), Univ. of Washington, 2020. [Online]. Available: https://ghdx.healthdata.org/gbd-2020
V. Jha, G. Garcia-Garcia, K. Iseki, Z. Li, S. Naicker, B. Plattner, et al., “Chronic kidney disease: Global dimension and perspectives,” The Lancet, vol. 398, no. 10294, pp. 1205–1219, 2021. [Online]. Available: https://doi.org/10.1016/S0140-6736(21)00519-5
Indonesian Renal Registry (IRR), Indonesian Renal Registry Report 2023. Jakarta, Indonesia: Indonesian Society of Nephrology (PERNEFRI), 2023. [Online]. Available: https://www.indonesianrenalregistry.org/
R. Hasanah, W. Utomo, and M. Rustam, “Physical activity patterns among elderly patients with hypertension at Simpang Tiga Primary Health Center,” Journal of Health and Nutrition Sciences, vol. 1, no. 1, 2023. [Online]. Available: https://johans.id/index.php/johans/article/view/10
D. Nopriani and H. Sutami, “Hypertension and diabetes mellitus as major predictors of chronic kidney disease among hemodialysis patients,” Indonesian Journal of Health Epidemiology, vol. 8, no. 1, pp. 33–41, 2024. [Online]. Available: https://jurnal.harianregional.com/eum/id-80236
A. Hussein, “Family history as a determinant of chronic kidney disease: Evidence from Ethiopia,” African Journal of Nephrology, vol. 24, no. 1, pp. 67–74, 2020. [Online]. Available: https://doi.org/10.21804/24-1-4042
C. G. Okwuonu, “Family history and chronic kidney disease risk in Nigeria,” West African Journal of Medicine, vol. 34, no. 2, pp. 122–128, 2017. [Online]. Available: https://www.ajol.info/index.php/wajm/article/view/160557
A. Triwahyuni, “Risk determinants of chronic kidney disease among outpatient populations in Central Sulawesi,” Journal of Tropical Health, vol. 14, no. 2, pp. 88–97, 2024. [Online]. Available: https://perpus-utama.poltekkes-malang.ac.id/assets/file/jurnal/Jil._21_No_.2_(2023)_.pdf
A. Köttgen, C. Pattaro, C. A. Böger, et al., “Genome-wide association studies identify genetic loci associated with kidney function and chronic kidney disease,” Nature Genetics, vol. 45, no. 6, pp. 712–719, 2013. [Online]. Available: https://doi.org/10.1038/ng.2601
I.-C. Kuo, S.-C. Wang, C.-C. Chang, et al., “Urinary tract infection and kidney function decline in patients with chronic kidney disease: A prospective cohort study,” BMC Nephrology, vol. 21, p. 145, 2020. [Online]. Available: https://doi.org/10.1186/s12882-020-01813-1
RSUD Dr. Moewardi Hospital, Report on Urinary Tract Infection and Chronic Kidney Disease Cases in 2023. Surakarta, Indonesia, 2023. [Online]. Available: https://rsmoewardi.jatengprov.go.id/
Clinical Kidney Journal Editorial Board, “Cardiorenal syndrome: Pathophysiological interactions between the heart and kidneys,” Clinical Kidney Journal, vol. 16, no. 3, pp. 485–498, 2023. [Online]. Available: https://doi.org/10.1093/ckj/sfac225
R. Vasques and A. Costa, “Pathophysiology and clinical aspects of cardiorenal syndrome,” International Journal of Molecular Sciences, vol. 26, no. 4, p. 1893, 2025. [Online]. Available: https://doi.org/10.3390/ijms26041893
M. C. Thomas, M. E. Cooper, and P. Zimmet, “Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease,” Nature Reviews Nephrology, vol. 17, pp. 133–145, 2021. [Online]. Available: https://doi.org/10.1038/s41581-020-00342-8
R. Z. Alicic, M. T. Rooney, and K. R. Tuttle, “Diabetic kidney disease: Challenges, progress, and possibilities,” Clinical Journal of the American Society of Nephrology, vol. 12, no. 12, pp. 2032–2045, 2017. [Online]. Available: https://doi.org/10.2215/CJN.11491116
N. M. Hustrini, D. P. Soetedjo, S. D. Widyastuti, et al., “The etiology of kidney failure in Indonesia: A multicenter study in tertiary-care centers in Jakarta,” Annals of Global Health, vol. 89, no. 1, p. 36, 2023. [Online]. Available: https://doi.org/10.5334/aogh.3950
V. Jha, G. Garcia-Garcia, K. Iseki, et al., “Chronic kidney disease: Global dimension and perspectives,” The Lancet, vol. 382, no. 9888, pp. 260–272, 2013. [Online]. Available: https://doi.org/10.1016/S0140-6736(13)60687-X
R. M. Carey, D. A. Calhoun, G. Bakris, et al., “Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association,” Hypertension, vol. 79, no. 12, pp. e93–e109, 2022. [Online]. Available: https://doi.org/10.1161/HYP.0000000000000204
S. R. Orth and S. I. Hallan, “Smoking: A risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients,” Clinical Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 754–762, 2018. [Online]. Available: https://doi.org/10.2215/CJN.11491117
K. Yamagata, S. Ishida, T. Sairenchi, et al., “Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study,” Kidney International, vol. 92, no. 3, pp. 572–582, 2017. [Online]. Available: https://doi.org/10.1016/j.kint.2017.12.020
J.-M. Halimi, A. Mimran, and M. Metzger, “The role of smoking in chronic kidney disease: Epidemiology, mechanisms, and prevention,” Journal of Nephrology, vol. 34, pp. 1785–1798, 2021. [Online]. Available: https://doi.org/10.1007/s40620-021-01020-4
I. G. R. Widodo, I. P. E. Widyadharma, and D. K. Wati, “Smoking as a risk factor for decreased renal function among Indonesian patients: A hospital-based study,” Jurnal Ners, vol. 17, no. 2, pp. 157–164, 2022. [Online]. Available: https://journal.unair.ac.id/JNERS/article/view/33839
S. A. Musa, M. M. Fawzi, and R. H. Al-Rifai, “Health risks of energy drink consumption: A narrative review of cardiovascular, renal, and metabolic outcomes,” Journal of Human Health Research, vol. 5, no. 2, pp. 45–58, 2022. [Online]. Available: https://jhhr.ojs.io/index.php/jhhr/article/view/52
A. A. Alsunni, “Energy drinks: Health risks and toxicity,” International Journal of Health Sciences, vol. 9, no. 4, pp. 361–367, 2015. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764147/
A. S. Alrasheed, M. H. Al-Qahtani, and F. A. Alghamdi, “Effects of energy drink consumption on kidney function biomarkers among young adults in Saudi Arabia,” Journal of King Abdulaziz University – Medical Sciences, vol. 28, no. 3, pp. 125–133, 2021. [Online]. Available: https://www.scirp.org/pdf/jbm_2023032915451692.pdf
A. C. Webster, E. V. Nagler, R. L. Morton, and P. Masson, “Chronic kidney disease,” The Lancet, vol. 389, no. 10075, pp. 1238–1252, 2017. [Online]. Available: https://doi.org/10.1016/S0140-6736(16)32064-5
C. Ronco, A. Bellasi, and L. Di Lullo, “Cardiorenal syndrome: The complex crosstalk between heart and kidney,” Heart Failure Reviews, vol. 25, no. 4, pp. 1–14, 2020. [Online]. Available: https://doi.org/10.1007/s10741-019-09844-5
DOI: https://doi.org/10.37311/jsscr.v8i1.36097
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Journal Syifa Sciences and Clinical Research
| EDITORIAL OFFICE OF JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH |
| Department of Pharmacy, Gorontalo State University Jl. Jenderal Sudirman No.6, Kota Gorontalo, Provinsi Gorontalo 96128, Indonesia |
| Email: [email protected] Google Scholar : JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH |
